Efgartigimod therapy for immune checkpoint inhibitor-associated myasthenia gravis with myositis: a case report. [PDF]
Qi F, Sun Q, Wang H, Zhang Y.
europepmc +1 more source
Before Coming to the Conclusion That Inclusion Body Myositis Is a Risk Factor for a Heart Attack, All Influencing Factors Must Be Taken Into Account. [PDF]
Finsterer J, Zarrouk S.
europepmc +1 more source
Non-traumatic clostridial myositis: an unusual feature of brain death
J.P. Thys, P Ectors, Philippe Noël
openalex +1 more source
Warning from a pediatric patient with severe myositis ossificans combined with femoral fracture: a case report. [PDF]
Wang M, Cao J, Zhu H.
europepmc +1 more source
Immune Checkpoint Inhibitor-Induced Myositis, Myocarditis, and Myasthenia Gravis Overlap Syndrome Following Nivolumab and Ipilimumab Combination Therapy in a 60-Year-Old Male With Metastatic Renal Cell Carcinoma. [PDF]
Ismail U.
europepmc +1 more source
Predictors of persistent active disease and the longitudinal development of organ damage, patient-reported outcomes and autoantibodies in long-term juvenile dermatomyositis. [PDF]
Berger SG+6 more
europepmc +1 more source
Juvenile dermatomyositis in Oman: clinical patterns and disease trajectory from a National cohort. [PDF]
Abdwani R+5 more
europepmc +1 more source
A case of Haemophilus parainfluenzae meningitis in an adult associated with acute myositis
A Timmis, Erik Nyholm, Rodney Dawson
openalex +1 more source
Difference in Expression of Phosphorylated Tau Epitopes between Sporadic Inclusion-body Myositis and Hereditary Inclusion-body Myopathies [PDF]
Massimiliano Mirabella+4 more
openalex +1 more source
The clinical features, muscle pathology, and role of autophagy in anti-Ku-positive patients. [PDF]
Qiao L+6 more
europepmc +1 more source